Clinical Trials Logo

Ovarian Endometrioid Tumor clinical trials

View clinical trials related to Ovarian Endometrioid Tumor.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04510584 Withdrawn - Clinical trials for Fallopian Tube Cancer

Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer

Start date: July 16, 2021
Phase: Phase 2
Study type: Interventional

This study is being done to look at the combination of the drugs atezolizumab and bevacizumab as a maintenance treatment (treatment given after the main treatment to keep the cancer from coming back or worsening) following standard therapy in patients with high grade ovarian, fallopian tube, or primary peritoneal cancer with a mutation (change) in a gene called TP53. Genes are molecules in the body that are made up of deoxyribonucleic acid (DNA) and control how the body's cells behave.